mercaptopurine
Drug Details
- Generic Name
- mercaptopurine
- Brand Names
- Mercaptopurine
- Application Number
- ANDA040594
- Sponsor
- Mylan Pharmaceuticals Inc.
- NDC Codes
- 1
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- MERCAPTOPURINE
Indications and Usage
1 INDICATIONS & USAGE Mercaptopurine tablets is a nucleoside metabolic inhibitor indicated for treatment of adult and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen. (1.1) 1.1 Acute Lymphoblastic Leukemia Mercaptopurine tablets are indicated for treatment of adult and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.